Pfizer wants U.S. to approve COVID vaccine for 5- to 11-year olds


Pfizer and BioNTech have officially requested that the U.S. Government allow children ages 5 to 11 to be given its Covid-19 vaccine, Pizer announced in a Tweet this morning.

If the Federal Drug Administration approves its application children could begin getting immunized within the month, according to the Los Angeles Times.

Pfizer reported last month that company data showed its Covid-19 vaccine to be safe and effective in children ages 5 to 11. The FDA will convene a panel of experts to debate the evidence on Oct. 26.

Younger children given two doses — each a third the strength of adult doses — develop the same virus-fighting antibody levels as older people who were given full doses of the vaccine, according to the Los Angeles Times.

Although children are at lower risk of severe illness or death than adults, children’s cases have risen sharply since the return to school this fall amid the more contagious delta variant.

Leave a Reply

The Exedra comments section is an essential part of the site. The goal of our comments policy is to help ensure it is a vibrant yet civil space. To participate, we ask that Exedra commenters please provide a first and last name. Please note that comments expressing congratulations or condolences may be published without full names. (View our full Comments Policy.)

Your email address will not be published. Required fields are marked *